Composition for therapeutic and cosmetic botulinum toxin
AssigneeBotulinum Toxin Research Associates, Inc.
InventorGary Borodic
Life of this patent
Estimating the term…
Abstract
This invention relates to a composition of botulinum based pharmaceuticals used for therapeutic and cosmetic treatment. This invention offers an improvement on the prior art by eliminating the potential of blood-borne contamination with botulinum based pharmaceuticals. Recombinant serum albumin is taught for use in the place of human serum albumin as a stabilizing or enhancing agent.
Claims18
A pharmaceutical composition comprising a botulinum neurotoxin and a recombinant serum albumin at a concentration greater than 2.0 mg/cc per 20 mouse LD50 units of neurotoxin.
A pharmaceutical composition comprising a botulinum neurotoxin and a recombinant serum albumin at a concentration greater than 0.5 mg/cc per 5 mouse LD50 units of neurotoxin.
Dependencies are inferred from the claim text.